FDA Regulatory Counsel combines go-to national subject matter expertise with the transactional experience of hundreds of middle market deals. Our attorneys perform business-minded diligence for M&A, corporate finance, VC and PE, drawing on our familiarity with current market and a deep well of industry history. We are experienced on buy and sell side transactions, and have considerable experience working on initial divestitures with original founders.

As regulatory specialists, we also understand that each transaction comes with its own ecology and we deliver insight accordingly; we can work alongside your team or advise behind the scenes. We advise some of the most prolific health care lenders and investors in the country and provide regulatory expertise for law firms without in-house FDA counsel. With advanced degrees and decades of experience, FDARC has the insight necessary to advise on the risk and mitigation of compliance issues. We are also available to provide post-event oversight and sit as advisory board members.

Compliance diligence is a high-stakes necessity because the FDA is the ultimate arbiter of a company's ability to sell its products in the U.S. From regulatory posture and financial prospects to potential liability and post-event compliance monitoring, expert review can mean the difference between absorbing and apportioning risk. Moreover, applying our knowledge of the intricacies of FDA law to a target company often reveals unrecognized revenue streams. Ultimately, FDARC performs pragmatic, tailored diligence enabling our clients to make the most informed business decisions.